Healthcare • Drug Manufacturers - Specialty & Generic
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if COLL is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
33 top institutions tracked
Last 13F trend: unchanged (light)
Unlock crowding heatmapUnlock filer discoverySentiment: unknown
No recent insider trades detected.
Red flags: 1
278 filers reported a long position in COLL for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| BlackRock, Inc. | $197M | 5.4M | +6% |
| Jupiter Topco LLC | $77.7M | 2.1M | — |
| Invesco Ltd. | $68.1M | 1.9M | +18.3% |
| FULLER & THALER ASSET MANAGEMENT, INC. | $59.1M | 1.6M | +8.9% |
| PRINCIPAL FINANCIAL GROUP INC | $59.1M | 1.6M | +26% |
| STATE STREET CORP | $55.3M | 1.5M | +7.3% |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | $50.9M | 1.4M | +2.9% |
| VANGUARD CAPITAL MANAGEMENT LLC | $50M | 1.4M | +3.5% |
| RENAISSANCE TECHNOLOGIES LLC | $49.5M | 1.4M | -7% |
| EVENTIDE ASSET MANAGEMENT, LLC | $49.3M | 1.4M | -4.4% |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.